Rita M. O'Connor
2021
In 2021, Rita M. O'Connor earned a total compensation of $1.8M as Chief Financial Officer and Head of Manufacturing and Supply Chain at Dipexium Pharmaceuticals, a 28% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $202,125 |
|---|---|
| Option Awards | $1,166,000 |
| Salary | $404,250 |
| Other | $16,850 |
| Total | $1,789,225 |
O'Connor received $1.2M in option awards, accounting for 65% of the total pay in 2021.
O'Connor also received $202.1K in non-equity incentive plan, $404.3K in salary and $16.9K in other compensation.
Rankings
In 2021, Rita M. O'Connor's compensation ranked 6,481st out of 12,397 executives tracked by ExecPay. In other words, O'Connor earned more than 47.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,481 out of 12,397 | 48th |
Division Manufacturing | 2,775 out of 5,492 | 50th |
Major group Chemicals And Allied Products | 1,224 out of 2,367 | 48th |
Industry group Drugs | 1,092 out of 2,090 | 48th |
Industry Pharmaceutical Preparations | 791 out of 1,537 | 49th |
Source: SEC filing on September 29, 2022.
O'Connor's colleagues
We found two more compensation records of executives who worked with Rita M. O'Connor at Dipexium Pharmaceuticals in 2021.